Market Size of Brazil Mammography Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 44.97 Million |
| Market Size (2029) | USD 70.09 Million |
| CAGR (2024 - 2029) | 9.28 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Brazil Mammography Market Analysis
The Brazil Mammography Market size is estimated at USD 44.97 million in 2024, and is expected to reach USD 70.09 million by 2029, growing at a CAGR of 9.28% during the forecast period (2024-2029).
The COVID-19 pandemic has directed the requirement for health services adjustments that have compromised the management of other major diseases. For cancer patients, interruptions have drastically damaged the outcomes in some circumstances. The impact of the COVID-19 pandemic on cervical and breast cancer diagnosis and treatment procedures contrasted to the same time before the pandemic was substantial. The amount of breast cancer identifications owing to screening tests also reduced during the pandemic. These reductions confirm the long-term deleterious impacts of the COVID-19 pandemic on breast cancer patients in Brazil.
On account of temporary closures of National Breast Screening Programs, the country witnessed a drop in mammography procedures. Furthermore, the Brazilian National Health Agency (Agência Nacional de Saúde - ANS) announced the postponement of procedures, exams, and visits that were considered to be non-urgent during the lockdown in the year 2020. This greatly impacted the breast screening services across Brazil. For instance, in the city of Fortaleza, Brazil mammogram screening witnessed a decline of approximately 95% in 2020. Additionally, according to a Brazilian public health system cross-sectional study, a decrease in mammography procedures of around 42% was registered across the country from the year 2019 to the year 2020.
The major factors influencing the market growth in Brazil includes growing burden of Breast cancer and rising technological advancements in the field of breast imaging.
Breast cancer is becoming one of the leading causes of death in the women population of Brazil. The country already has the highest incidence of breast cancer in the South American region. According to the estimates of GLOBOCAN, there are around 88,492 new cases and 20,725 deaths reported due to breast cancer in Brazil. The high burden of breast cancer is expected as many patients seek treatment at hospitals where mammography screening is done. This is expected to boost the market growth during the forecast period.
